booksshare.net -> -> -> . -> " " -> 260

- .

. .: , 2007. 608 c.
ISBN 5-98657-009-
( ): pharmazeutischewirkstoffe1982.djvu
<< 1 .. 254 255 256 257 258 259 < 260 > 261 262 263 264 265 266 .. 345 >>

DOS 2 924 231 (P. Gargani; Anm. 15.6.1979; I-Prior. 16.6.1978).
D: Mercaptopropionylglycin (Fresenius) J; Thiola® (Santen)
I: Mucolysin® (Proter)
Thiola® Sanien (Coop. Farm.) Thiosol® (Coop. Farm.)
894 T Tiotixen - Tioxolon
TiOtixen 3313-26-6 Neurolepticum
(Thiothixen) 22189-31-7 Dihydrochlorid-Dihydrat
jV,jV-dimethyl-9-[3-(4-methyl-l-piperazinyl)propylidene]-thioxanthene-2-sulfonamide
1 SOCI;
,ch
2. HN4
!L J! J ♦ ci—so3h ------sosH
9W-Thioxanthen Chlorsulfon- 9H-Thioxanthen-
saure 2-sulfonsaure
V Thionylchlorid 2. Dimethylamin
CH3
S02—N
2-Dimethylaminosulfonyl-
9H-thioxanthen
1. CtH9li
2. CH3COOCH3
). Butyllithium 2. Essigsaure-methylester
so2
CO-CH3
CH3
9-Acetyl-2-dimethylannino-
sulfonyt-9W-thioxanthen
CH2Q/HN(CH3li i
Formaldehyd/
Dimethylamin
Tiotixen
DOT 4,163 (1968); 9,229 (1973).
USP 3 310 553 (Pfizer; ert. 21.3.1967; Anm. 26.4.1963; Prior. 25.9.1962). DBP 1 470 157 (Pfizer; Anm. 24.9.1963; USA-Prior. 25.9.1962; 26-4.1963). J. F. Muren u. В. M. Bloom, J. Med. Chem. 13,17 (1970).
D: Orbinamon® (Pfizer) J: Navane® (Taito-Pfizer)
GB: Navane® (Pfizer) USA: Navane® (Roehrig)
I: Navane® (Pfizer)
Tioxolon 4991-65-5 Antiseborrhoicum
6-hydroxy-1,3*benzoxathioi-2-one
Tioxolon - Tipepidin - Tixocortolpivaiat T 895
+ NH/.SCN
ICuSOJ
HO
Resorcin Ammonium -
rhodanid
Tioxolon
USP 2 332 418 (Winthrop; ert. 1943; D-Prior. 1938). Anwendung:
USP 2886488 (Thomae; ert. 12.5.1959; D-Prior. 2.7.1955).
D: Stepin® (Basotherm)
F: Gelacnine® (Lab. du D’Furt)
I: Wasacne® (Wassermann) J: Vikura® (Eisai)
Tipepidin
5169-78-8
Antitussivum
31139-87-4 4-Hydroxybenzo-phenon-2-carboxylat (Hibenzoat) 5169-77-7 Citrat
3-(di-2-thienylmethylene)-l-methylpiperidine
Span-P272195 (A. Gallardo; Anm. 20.11.1961).
(auch Citrat)
Weitere Literatur - siehe Citrat Hibenzoat:
JP 17591 (62') Tanabe Seiyaku; Anm. 27.10.1962, Prior. 19.10.1960).
GB-P 924 544 (Tanabe Seiyaku; Laufzeit ab 7.12.1961; J-Prior. 19.12.1960).
Citrat:
A. A. Ponomarev, N. I. Martemjanova, Khim. Geterotsikl. soedin. 1957,174.
USSR-P 176 903 (Ponomarev, Martemjanova; Anm. 27.10.1962).
I: Asverin® (ISF) Asverin®-H (Hibenzoat) (Tanabe)
J: Asverin® (Tanabe Seiyaku) Hustopan®-Syr. (Ohta)-Komb.
Tixocortolpivaiat 55560-96-8 Glucocorticoid
(Tiocortisolpivalat, 61951-99-3 Tixocortol Tixocortoltrimethylacetat)
11Д17-dihydroxy-21 -mercaptopregn-4-ene-3,20-dione 21 - trimethylthioacetate
Nrcotir saureethyl-ester
1 [ С НзО) 2SO2 2. H2/Ni
896 T Tixocortolpivalat - Tobramycin
i-сн.
11/3,17-Dihydroxy-3,20-dioxo-21-jod-A-pregnen (S. S. 473)
/?
+ IH3C)3C-C
Aceton/NaOCH3
SH
Trimethylthio-
essigsaure
DOS 2357 778 (Jouveinal; Anm. 20.11.1973; F-Prior. 30.5.1973). Synthese von Tixocortol:
R. E. Schaub, M. J. Weiss, J- Org. Chem. 26,1223 (1961).
F: Pivalone Bouche® (Jouveinal)-Komb.
Pivalone® Collutoire (Jouveinal)-Komb.
Pivalone® Nasale (Jouveinal)-Komb. Pivalone® Oto (Jouveinal)-Komb.
Tobramycin
32986-56-4 49842-07-1 Sulfat
Antibioticum
* D-streptamine, 03-amino-3-deoxy-a-D-glucopyranosyl-(l—»6)-0[2,6-diamino-2,3,6-trideoxy-a-D-ribo-hexopyranosyI-(l—»4)]-2-deoxy-
a Aus Fermentationslosungen von Streptomyces tenebrarius [AT CC 17920] oder [AT CC17921].
Bekanamycin [Kanamyctn 8] (S. S. 75)
ATP ' E-eoli R11 (IFO-13560) Adenosmtnphosphat
nh2
a USP 3691 279 (Lilly; ert. 12.9.1972; Prior. 15.4.1970,12.2.1969,17.9.1965). b DOS 2 514 985 (Takeda; Anm. 5.4.1975; J-Prior. 10.4.1974, 25.6.1974).
T. Okutani et al., J. Am. Chem. Soc. 99,1278 (1977).
Tobramycin - a-Tocopherol/a-Tocopherolacetat T 897
Weitere Verfahren:
DOS 2 361 159 (Zaidan Hojin Biseibutsu Kagaku Kenkyu Kai; Anm. 7.12.1973; J-Prior. 8.12.1972). DOS 2 533 985 (Meiji Seika Kaisha; Anm. 30.7.1975; J-Prior. 1.8.1974).
Y. Tagaki et al., J. Antibiot. 26,403 (1973).
Totalsynthese:
M. Tanabe et al., Tetrahedron Lett. 1977, 3607.
D: Gernebcin® (Lilly) I: Nebicina® (Lilly)
F: Nebcine® (Lilly) J: Tobracin® (Shionogi Seiyaku)
GB: Obracin® (Dista) USA: Nebcin® (Lilly)
a-Tocopherol/ a-T ocopherolacetat
(Vitamin E/Vitamin E-Acetat)
10191-41-0 D,L-Verbindung 59-02-9 D-Verbindung 7695-91-2 d,l-6-Acetat 58-95-7 D-6-Acetat
Antisterilitatsvitamin
‘ 2//-l-benzopyran-6-oI, 3,4-dihydro-2,5,7,8-tetramethyl-2-(4,8,12-trimethyl-tridecyl)-
Totalsynthese
CH3
CH3
2,3,5-Trimethyl-
hydrochinon
I saure Kordensationsmittel)
Isophytol
CH3
НзС X. 0
'CH
HO
CH3
CH3 CH3 о, L-of-Tocopherol
.CH3
CH3
I D, L-a-Tocopherolacetat I
b Partialsynthese (aus den in Pflanzenolen gemeinsam mit a-Tocopherol vorkommenden /?-, y- und &-Tocopherolen), z.B. ausgehend von /-Tocopherol:
СНЭ СНз CH3 сн
НЗСЙС6Н33 --h^h— НзС)фС?''бН33 a-Tocophero1
7-Tocopherol CH2-CI
a DRP 713 749 (Roche; Anm. 1939; CH-Prior. 1938).
DRP 731 972 (Roche; Anm. 1938; CH-Prior. 1938).
DBP 960720 (Roche; Anm. 1955; USA-Prior. 1954).
DAS 1 909 164 (Roche; Anm. 24.2.1969; USA-Prior. 27.2.1968,19.11.1968).
DAS 2 208 795 (Diamond Shamrock; Anm. 24.2.1972; USA-Prior. 25.2.1971).
<< 1 .. 254 255 256 257 258 259 < 260 > 261 262 263 264 265 266 .. 345 >>

c1c0fc952cf0704ad12d6af2ad3bf47e03017fed

, ?
2009 BooksShare.
.
Rambler's Top100

c1c0fc952cf0704ad12d6af2ad3bf47e03017fed